GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Greenrose Holding Co (OTCPK:GNRUQ) » Definitions » Risk Assessment

GNRUQ (The Greenrose Holding Co) Risk Assessment


View and export this data going back to 2020. Start your Free Trial

What is The Greenrose Holding Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of The Greenrose Holding Co is: No Data: Cannot be evaluated.


Competitive Comparison of The Greenrose Holding Co's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Greenrose Holding Co's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's Risk Assessment falls into.


;
;

The Greenrose Holding Co  (OTCPK:GNRUQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


The Greenrose Holding Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of The Greenrose Holding Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


The Greenrose Holding Co Business Description

Traded in Other Exchanges
N/A
Address
111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.
Executives
Bernard Wang officer: CHIEF FINANCIAL OFFICER 5575 TERRACE DR., LA CRESCENTA CA 91214
Benjamin Rose director 10115 JEFFERSON BOULEVARD, CULVER CITY CA 90232
True Harvest, Llc 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Michael Macchiaroli 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Scott Jeffrey Cohen officer: Chief Financial Officer C/O GREENROSE ASSOCIATES LLC, 111 BROADWAY, AMITYVILLE NY 11701
Greenrose Associates Llc 10 percent owner 1000 WESTBURY AVENUE, WESTBURY NY 11590
Steven Francis Cummings director, 10 percent owner 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
Daniel Patrick Harley director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
John Iii Torrance director, 10 percent owner 1000 WOODBURY ROAD, WOODBURY NY 11797
Thomas J Megale director 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
John Falcon director, 10 percent owner 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Jeffrey Stegner 10 percent owner, officer: Chief Financial Officer 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Brendan Sheehan director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
William Iii Harley director, 10 percent owner, officer: Chief Executive Officer 1000 WOODBURY ROAD, WOODBURY NY 11797
Paul Otto Wimer 10 percent owner, officer: President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797